TestosteroneTestosterone Esters Research Reference by QSC Peptides — Test E, Test C, Test P, Suspension

Testosterone (17β-hydroxy-4-androsten-3-one) is the primary male sex hormone — a C19 steroid produced mainly in Leydig cells of the testes. It is the endogenous agonist of the androgen receptor (AR), a nuclear receptor that regulates gene expression governing muscle protein synthesis, bone density, erythropoiesis, and secondary sexual characteristics.

Testosterone binds AR with full agonist activity (Kd ~1 nM). The ligand-bound AR homodimerizes, translocates to the nucleus, and binds androgen response elements (ARE: 5'-TGTTCT-3') in promoters of target genes. Key anabolic target genes include: IGF-1, MyHC (myosin heavy chain), follistatin (myostatin antagonist), and nitrogen retention factors.

Aromatization — CYP19A1

Testosterone is a substrate for aromatase (CYP19A1), which converts it to estradiol (E2) in adipose tissue, muscle, liver, and brain. E2 exerts anabolic effects through estrogen receptor alpha (ERα) — contributing to bone mineral density and potentially muscle mass. This aromatization distinguishes testosterone from DHT derivatives and 19-nor compounds in research.

5α-Reduction — DHT Conversion

5α-reductase converts testosterone to dihydrotestosterone (DHT) in skin, prostate, and scalp. DHT binds AR with 3–5× higher affinity than testosterone, mediating androgenic effects in androgen-sensitive tissues. This is why DHT-derived AAS (Anavar, Winstrol, Masteron) have different androgenic profiles than testosterone.

Ester Pharmacokinetics

The ester bond determines release kinetics from the injection depot. Longer carbon chains = slower hydrolysis = longer half-life. QSC Peptides offers: Enanthate (C7, ~7 day t½), Cypionate (C8, ~8 day t½), Propionate (C3, ~2 day t½), and Suspension (no ester, <1 day t½).